Surging Nuclear Demand in the U.S. Drives Uranium Prices Up
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy LEU?
Source: Fool
- Nuclear Production Goals: The U.S. Department of Energy aims to triple nuclear energy production by mid-century to address the anticipated power crunch as AI is projected to consume electricity equivalent to 22% of all American households by 2028, highlighting a strategic pivot towards nuclear energy.
- Uranium Price Surge: Over the past year, uranium's spot price has risen by 38%, contrasting with declines in other energy resources, indicating a sustained market demand for uranium, particularly in light of increasing nuclear energy requirements.
- Centrus Expansion Investments: Centrus Energy announced a $560 million investment in its Oak Ridge centrifuge plant and a multibillion-dollar expansion of its Ohio facility in partnership with Fluor to meet the growing uranium demand, further solidifying its market position as a leading uranium enricher.
- Strong Financial Performance: Centrus achieved a 5.6% net income growth for the fiscal year 2025 and a 13% compound annual growth rate in revenue from 2020 to 2025, while its cash reserves nearly tripled from $671.4 million to $1.95 billion, reflecting a robust financial health and ongoing investment capability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LEU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LEU
Wall Street analysts forecast LEU stock price to rise
14 Analyst Rating
10 Buy
4 Hold
0 Sell
Moderate Buy
Current: 188.890
Low
117.00
Averages
297.10
High
390.00
Current: 188.890
Low
117.00
Averages
297.10
High
390.00
About LEU
Centrus Energy Corp. is a supplier of nuclear fuel components for the nuclear power industry. Its segments include Low-Enriched Uranium (LEU) and Technical Solutions. Its LEU segment supplies various components of nuclear fuel to commercial customers from its global network of suppliers. The LEU segment consists of two components: SWU and natural uranium hexafluoride. It supplies LEU and its components to both domestic and international utilities for use in nuclear reactors worldwide. It provides LEU from multiple sources, including its inventory, medium- and long-term supply contracts, and spot purchases. It also sells natural uranium hexafluoride and occasionally sells uranium concentrates. The Technical Solutions segment provides advanced engineering, design, and manufacturing services to government and private sector customers. It is deploying uranium enrichment and other capabilities necessary to produce advanced nuclear fuel to power existing reactors around the world.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Nuclear Economics Strengthened: As oil prices surge to $120 per barrel, utilities and policymakers are seeking stable alternatives, with nuclear power gaining renewed attention due to its relatively low fuel costs, likely prompting investors to rotate into uranium and nuclear-related companies.
- Rising Power Demand: The surge in electricity demand from artificial intelligence infrastructure is pushing large data centers to require reliable power, leading tech companies and utilities to explore long-term power sources, with nuclear operators like Constellation Energy Corp positioned to benefit from this trend.
- Market Dynamics Shifting: The nuclear sector has been overshadowed by cheap natural gas and renewable energy in recent years, but the rise in oil prices and increasing electricity demand may bring nuclear trading back into focus for investors, altering the market landscape.
- Investor Interest Reignited: Companies linked to the nuclear fuel supply chain, such as Cameco Corp and Centrus Energy Corp, are gradually gaining investor attention due to their significant roles in the nuclear market, expected to benefit from the volatility in the energy market.
See More
- Joint Venture Exploration: Oklo Inc. and Centrus Energy Corp. announced plans to explore a joint venture for high-assay low-enriched uranium (HALEU) deconversion services at Centrus' Piketon site in Ohio, aiming to enhance efficiency and reduce costs through integrated uranium enrichment and deconversion processes.
- Nuclear Supply Chain Rebuilding: Oklo CEO Jacob DeWitte emphasized that advanced nuclear energy development requires not only reactors but also reliable fuel-cycle capabilities, highlighting the importance of rebuilding the U.S. nuclear fuel supply chain to meet growing demands.
- Technical Analysis Signals: Oklo's stock is currently trading 11.5% below its 20-day SMA and 38.6% below its 100-day SMA, indicating a bearish trend in the medium term; however, the MACD shows potential upward momentum, suggesting mixed market sentiment.
- Analyst Ratings and Outlook: Oklo's stock carries a Buy rating with an average price target of $110.88, and despite recent target downgrades by analysts, the overall strong market performance indicates investor confidence in its future prospects.
See More
- Joint Venture Development: Oklo and Centrus Energy announced plans to explore the creation of a joint venture at Centrus' Piketon site in Ohio, focusing on deconversion services for high-assay low-enriched uranium, aiming to enhance efficiency and reduce costs through co-location.
- Domestic Nuclear Capacity Expansion: The joint venture is strategically positioned next to Centrus' enrichment operations, intending to integrate uranium enrichment and deconversion services to expand domestic advanced nuclear fuel production capacity and address potential bottlenecks in large-scale nuclear technology deployment.
- Technological and Supply Chain Advancements: Developing enrichment and deconversion services at the Piketon location is expected to improve overall efficiency and strengthen the stability of the domestic nuclear fuel supply chain, supporting the rapid advancement of nuclear technology.
- Strategic Collaboration Significance: This partnership not only aims to resolve nuclear fuel supply bottlenecks but also enhances the long-term strategic positioning of both companies in the nuclear energy sector, thereby increasing their market competitiveness.
See More
- Stock Surge: Centrus Energy's stock has skyrocketed over 7,200% in the past decade, although its high valuations may limit future upside potential, indicating a gradual recovery in market confidence towards nuclear energy.
- Revenue Fluctuations: Centrus' revenue plummeted from $1.86 billion in 2012 to $193 million in 2018, primarily due to a prolonged slump in nuclear demand following the Fukushima disaster; however, it is projected to grow to $449 million by 2025 at a 13% CAGR.
- Market Outlook: The International Atomic Energy Agency forecasts that global nuclear capacity could expand by up to 2.6 times from 2024 to 2050, with the HALEU market expected to grow faster than the LEU market, positioning Centrus favorably for future growth.
- Future Challenges: Despite having a backlog of $3.8 billion in orders by 2025, with analysts expecting revenue and adjusted EBITDA to grow at CAGRs of 5% and 22% from 2025 to 2028, Centrus' stock may face downward pressure due to high valuations.
See More
- Stock Surge Reasons: Centrus Energy's stock skyrocketed over 7,200% in the past decade primarily due to the recovery of the nuclear market post-Fukushima disaster, despite earlier demand suppression from halted nuclear projects.
- Revenue Fluctuations: Centrus' revenue plummeted from $1.86 billion in 2012 to $193 million in 2018; however, from 2018 to 2025, revenue is projected to grow at a 13% CAGR to $449 million, indicating a rebound in market demand.
- Market Outlook: The International Atomic Energy Agency forecasts that global nuclear capacity could expand by up to 2.6 times from 2024 to 2050, with Centrus poised for significant growth in the high-assay low-enriched uranium (HALEU) market, expecting revenue and EBITDA to grow at CAGRs of 5% and 22%, respectively, from 2025 to 2028.
- Future Challenges: Despite a backlog of $3.8 billion, analysts predict Centrus' revenue will grow at a 5% CAGR over the next decade, but if the stock trades at five times sales, it could decline by 5%, highlighting challenges in sustaining growth.
See More











